Dr. Evan Yu presents the new evidence-based guideline on genetic testing for metastatic prostate cancer. He discusses who should receive germline and somatic testing with next-generation sequencing ...

Final results of the OCEAN(a)-DOSE trial – published in the New England Journal of Medicine – showed that the small, interfering RNA (siRNA) drug reduced Lp(a) levels compared to placebo at ...

The US biotech has just reported phase 2 trial results with the small, interfering RNA (siRNA) gene-silencing drug showing that it an cause a 90% or greater reduction in Lp(a) levels – a risk ...

In this article, we are going to take a look at where Energy Transfer LP (NYSE:ET) stands against the other dividend stocks. Macroeconomic factors have weighed on US stocks in the final days of ...

Ulman Foundation Free oncology hospitality house in Baltimore, Maryland. Social navigators address patient-specific barriers including fertility preservation, financial need, and social support 28 ...

ARMONK, N.Y., Jan. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM) today announced its intent to acquire Applications Software Technology LLC 1, a global Oracle consultancy. Applications Software Technology ...

FILE - A person holds up LGTBQ+ pride flags during the Pride Parade in New York, June 24, 2018. NEW YORK (AP) — A national rights group said Tuesday that more U.S. companies are providing strong ...

Tombot, a robotic dog for people who can not have a real pet, gets a scratch during 2025 CES Unveiled, Sunday, Jan. 5, 2025, in Las Vegas. (AP Photo/Jack Dempsey) Tombot, a robotic dog for people ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

The FDA accepts Verastem's NDA for the accelerated approval of avutometinib to treat recurrent KRAS mutant ovarian cancer under priority review. The stock rises 41%. Verastem (VSTM) doses the ...

Getty Images / Thomas Barwick A master limited partnership (MLP) is an unusual investment that combines the tax benefits of a limited partnership (LP) with the liquidity of a common stock.